focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.50
Bid: 215.50
Ask: 216.00
Change: -2.00 (-0.92%)
Spread: 0.50 (0.232%)
Open: 211.00
High: 216.00
Low: 211.00
Prev. Close: 217.50
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of second share buyback programme of £30m

12 Mar 2024 07:01

RNS Number : 4274G
TP ICAP Group plc
12 March 2024

12 March 2024

TP ICAP Group plc

Launch of second share buyback programme of £30 million

Following the completion of its first buyback programme of £30 million in January 2024 (the "First Buyback"), TP ICAP Group plc (the "Company" or "TP ICAP") announces that it will commence a second share buyback programme, starting today, of TP ICAP's ordinary shares of 25p each (the "Ordinary Shares") for a maximum consideration of £30 million (the "Second Buyback", together with the First Buyback, the "Buybacks"), in order to reduce the capital of the Company and/or meet obligations under employee share schemes. Ordinary Shares purchased under the Buyback that are not cancelled will have their rights to dividend receipt waived by the Company.

The Second Buyback highlights the Board's confidence in the future prospects of TP ICAP, reflects its strong financial position, and is consistent with its dynamic capital management strategy, which is a key priority. This means reducing our debt, and returning surplus capital to shareholders, subject to our ongoing investment needs and balance sheet requirements.

TP ICAP is cash generative with a prudent capital management framework and the Board believes the Second Buyback strikes the appropriate balance between the continued and substantial investment in the Company's organic prospects such as Fusion, Liquidnet Credit, and Parameta Solutions, alongside reducing debt at a time when interest rates are high.

In line with the Company's clear dividend policy (a 50% pay-out ratio of adjusted post-tax earnings), the Board is recommending a final dividend of 10.0 pence per share, up 27%, which would bring the total 2023 dividend to 14.8 pence, an increase of 19%. The final dividend will be paid to eligible shareholders on 24 May 2024, with an ex-dividend and record date of 11 April 2024 and 12 April 2024, respectively.

In addition to the Buybacks, we freed up £100 million of cash before the end of 2023, ahead of schedule. This cash is being used to reduce debt and other financing obligations, lowering our future net finance costs, and increasing our investment grade headroom.

Subject to the Company's balance sheet and investment needs, we are assessing opportunities to free up more cash and pay down more debt, and/or return additional capital to shareholders.

Any share purchases will be made by the Company within certain pre-set parameters and in accordance with the general authority of the Company to repurchase shares granted by shareholders at the Company's Annual General Meeting held on 17 May 2023, which permits the Company to purchase no more than 78,867,093 ordinary shares (or 10% of the issued share capital). The Company bought back 16,925,189 shares in the First Buyback which was completed on 3 January 2024.

The Second Buyback will be conducted in compliance with Chapter 12 of the Financial Conduct Authority's Listing Rules and with European Union (EU) Regulation No 596/2014 ("MAR") and the MAR buyback technical standards (Commission Delegated Regulation (EU) 2016/1052) (the "Technical Standards"), both of which form part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018.

The Company will initially rely on the safe harbour conditions for trading set out in Article 3(2) and Article 3(3) of the Technical Standards. However, if the safe harbour conditions were to constrain the Company's ability to purchase the Second Buyback within the targeted timeframe given, for example, share illiquidity, the Company may subsequently decide and announce its intention to trade outside of the safe harbour conditions.

The Company has entered into an agreement with Peel Hunt LLP ("Peel Hunt") under which it has issued instructions (that are irrevocable during any closed period) to Peel Hunt to manage the Second Buyback as "matched" principal. Peel Hunt will carry out the Company's instructions through the acquisition of Ordinary Shares for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase Ordinary Shares. Peel Hunt will make its trading decisions independently of, and uninfluenced by, the Company during any closed periods of the Group.

Peel Hunt will undertake transactions in Ordinary Shares on any available trading venue or on an over-the-counter basis in order to execute the Second Buyback. Disclosure of such transactions will not be made by Peel Hunt as a result of or as part of the Second Buyback, but Peel Hunt will continue to make any disclosures it is otherwise legally required to make.

Details of any and all purchases made under the Second Buyback will be provided via RNS announcements by no later than 7.30 a.m. on the business day following the calendar day on which the purchase occurred and also published in the regulatory news section of the Group's website.

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Group. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Group's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

Enquiries:

Group Company Secretary Vicky Hart Email: companysecretarial@tpicap.com

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

About TP ICAP

·

TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

·

We are the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

·

We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSDDGDXLBBDGSB
Date   Source Headline
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights
1st Feb 20214:05 pmRNSResults of Court Meeting and General Meeting
1st Feb 20213:55 pmRNSResult of General Meeting - Liquidnet Acquistion
29th Jan 20211:05 pmRNSPublication of Suppl.Prospcts
25th Jan 20217:00 amRNSUpdate on Brexit Readiness Plan
7th Jan 20211:44 pmRNSCorporate Reorganisation - Documents Publication
7th Jan 20211:40 pmRNSPublication of Prospectus and Circular
7th Jan 20217:00 amRNSAnnouncement re: Rights Issue
7th Jan 20217:00 amRNSTrading Statement
17th Dec 202012:25 pmRNSHolding(s) in Company
15th Dec 20203:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.